PIRAMAL PHARMA
Back to All Ratios
|
PIRAMAL PHARMA Last 5 Year Total Debt/Mcap History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Total Debt/Mcap(x) | 0.27 | 0.67 | - | - |
What is the latest Total Debt/Mcap ratio of PIRAMAL PHARMA ?
Year | Total Debt/Mcap |
---|---|
Mar2024 | 0.27 |
Mar2023 | 0.67 |
Mar2022 | - |
Mar2021 | - |
How is Total Debt/Mcap of PIRAMAL PHARMA Trending?
Years | Total Debt/Mcap | % Change | |
---|---|---|---|
Mar2024 | 0.27 | -59.70 | |
Mar2023 | 0.67 | 0 | |
Mar2022 | 0 | 0 | |
Mar2021 | 0 | - |
Other Financial Ratios of PIRAMAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover |
Compare Total Debt/Mcap ratio of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹26,610.6 Cr | -5.1% | -4% | 27.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -5.1% |
-4% |
27.3% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses